Cargando…

Contribution of clinical breast exam to cancer detection in women participating in a modern screening program

PURPOSE: Despite the controversy surrounding the role of clinical breast exam (CBE) in modern breast cancer screening, it is widely practiced. We examined the contribution of CBE in women undergoing routine screening mammography and in women under the screening age. METHODS: A retrospective cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Menes, Tehillah S., Coster, Dan, Coster, Daniel, Shenhar-Tsarfaty, Shani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524962/
https://www.ncbi.nlm.nih.gov/pubmed/34666735
http://dx.doi.org/10.1186/s12905-021-01507-x
_version_ 1784585580493930496
author Menes, Tehillah S.
Coster, Dan
Coster, Daniel
Shenhar-Tsarfaty, Shani
author_facet Menes, Tehillah S.
Coster, Dan
Coster, Daniel
Shenhar-Tsarfaty, Shani
author_sort Menes, Tehillah S.
collection PubMed
description PURPOSE: Despite the controversy surrounding the role of clinical breast exam (CBE) in modern breast cancer screening, it is widely practiced. We examined the contribution of CBE in women undergoing routine screening mammography and in women under the screening age. METHODS: A retrospective cohort study including all women participating in a voluntary health screening program between 2007 and 2016. All participants undergo CBE; Screening mammography is done selectively based on age, breast imaging history and insurance coverage. Data collected included demographics, risk factors, previous imaging, and findings on CBE and mammography. Cancer detection rates within 3 months of the visit were calculated separately for women undergoing routine screening mammography, and women under the screening age. RESULTS: There were 14,857 CBE completed in 8378; women; 7% were abnormal. Within 3 months of the visit, 35 breast cancers (2.4 per 1000 visits) were diagnosed. In women within the screening age who completed a mammogram less than one year prior to the visit (N = 1898), 4 cancers (2.1 cancers per 1000 visits) were diagnosed. Only one was diagnosed in a woman with an abnormal CBE, suggesting that the cancer detection rate of CBE in women undergoing regular screening is very low (0.5 per 1000 visits). In women under the screening age (45), 3 cancers (0.4 per 1000 visits) were diagnosed; all were visualized on mammography, one had an abnormal CBE. CONCLUSIONS: The contribution of CBE to cancer detection in women undergoing routine screening and in women under the screening age is rare. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-021-01507-x.
format Online
Article
Text
id pubmed-8524962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85249622021-10-22 Contribution of clinical breast exam to cancer detection in women participating in a modern screening program Menes, Tehillah S. Coster, Dan Coster, Daniel Shenhar-Tsarfaty, Shani BMC Womens Health Research PURPOSE: Despite the controversy surrounding the role of clinical breast exam (CBE) in modern breast cancer screening, it is widely practiced. We examined the contribution of CBE in women undergoing routine screening mammography and in women under the screening age. METHODS: A retrospective cohort study including all women participating in a voluntary health screening program between 2007 and 2016. All participants undergo CBE; Screening mammography is done selectively based on age, breast imaging history and insurance coverage. Data collected included demographics, risk factors, previous imaging, and findings on CBE and mammography. Cancer detection rates within 3 months of the visit were calculated separately for women undergoing routine screening mammography, and women under the screening age. RESULTS: There were 14,857 CBE completed in 8378; women; 7% were abnormal. Within 3 months of the visit, 35 breast cancers (2.4 per 1000 visits) were diagnosed. In women within the screening age who completed a mammogram less than one year prior to the visit (N = 1898), 4 cancers (2.1 cancers per 1000 visits) were diagnosed. Only one was diagnosed in a woman with an abnormal CBE, suggesting that the cancer detection rate of CBE in women undergoing regular screening is very low (0.5 per 1000 visits). In women under the screening age (45), 3 cancers (0.4 per 1000 visits) were diagnosed; all were visualized on mammography, one had an abnormal CBE. CONCLUSIONS: The contribution of CBE to cancer detection in women undergoing routine screening and in women under the screening age is rare. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-021-01507-x. BioMed Central 2021-10-19 /pmc/articles/PMC8524962/ /pubmed/34666735 http://dx.doi.org/10.1186/s12905-021-01507-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Menes, Tehillah S.
Coster, Dan
Coster, Daniel
Shenhar-Tsarfaty, Shani
Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title_full Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title_fullStr Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title_full_unstemmed Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title_short Contribution of clinical breast exam to cancer detection in women participating in a modern screening program
title_sort contribution of clinical breast exam to cancer detection in women participating in a modern screening program
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524962/
https://www.ncbi.nlm.nih.gov/pubmed/34666735
http://dx.doi.org/10.1186/s12905-021-01507-x
work_keys_str_mv AT menestehillahs contributionofclinicalbreastexamtocancerdetectioninwomenparticipatinginamodernscreeningprogram
AT costerdan contributionofclinicalbreastexamtocancerdetectioninwomenparticipatinginamodernscreeningprogram
AT costerdaniel contributionofclinicalbreastexamtocancerdetectioninwomenparticipatinginamodernscreeningprogram
AT shenhartsarfatyshani contributionofclinicalbreastexamtocancerdetectioninwomenparticipatinginamodernscreeningprogram